<DOC>
	<DOCNO>NCT03020784</DOCNO>
	<brief_summary>Safety , Tolerability Pharmacokinetics PF-06818883</brief_summary>
	<brief_title>Safety Tolerability PF-06818883 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy female subject nonchildbearing potential and/or male subject Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence personally sign date informed consent document indicate subject inform pertinent aspect study Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease Any condition possibly affect placement intravenous drug administration line . A confirmed positive urine drug screen History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week male ( 1 drink = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month screen Use tobacco nicotinecontaining product excess equivalent 5 cigarette per day 2 chew tobacco per day Treatment investigational drug within 30 day ( determined local requirement ) Screening supine blood pressure &gt; 140 mm Hg ( systolic ) &lt; 90 mm Hg ( diastolic ) , follow least 5 minute supine rest Screening supine 12lead ECG demonstrate QTc &gt; 450 msec QRS interval &gt; 120 msec . Blood donation ( exclude plasma donation ) approximately 1 pint ( 500 mL ) within 60 day prior dose . History sensitivity heparin heparininduced thrombocytopenia History human immunodeficiency virus ( HIV ) , hepatitis B C ; positive testing HIV , hepatitis B surface antigen ( HepBsAg ) , hepatitis B core antibody ( HepBcAb ) hepatitis C antibody ( HCVAb ) . Other acute chronic medical psychiatric condition include recent ( within past year ) active suicidal ideation behavior laboratory abnormality may increase risk associate study participation investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>acute neuroinflammatory</keyword>
</DOC>